Inventor
DE MAN ADRIANUS PETRUS ANTONIUS
NL15 patents
⚠️ This page may combine multiple inventors who share the name “DE MAN ADRIANUS PETRUS ANTONIUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NETHERLANDS TRANSLATIONAL RES CENTER B V
8 patentsUSRE50082EAug 20, 2024
(5,6-dihydro)pyrimido[4,5-e]indolizines
NETHERLANDS TRANSLATIONAL RES CENTER B V0 citations58
USRE48974EMar 15, 2022
(5,6-dihydro)pyrimido[4,5-E]indolizines
NETHERLANDS TRANSLATIONAL RES CENTER B V1 citations58
US10494360B2Dec 3, 2019
Inhibitors of indoleamine 2,3-dioxygenase
NETHERLANDS TRANSLATIONAL RES CENTER B V1 citations56
US12054784B2Aug 6, 2024
Prognostic biomarkers for TTK inhibitor chemotherapy
NETHERLANDS TRANSLATIONAL RES CENTER B V0 citations53
US11208696B2Dec 28, 2021
Prognostic biomarkers for TTK inhibitor chemotherapy
NETHERLANDS TRANSLATIONAL RES CENTER B V0 citations53
US9856258B2Jan 2, 2018
(5,6-dihydro)pyrimido[4,5-E]indolizines
NETHERLANDS TRANSLATIONAL RES CENTER B V0 citations48
US11053230B2Jul 6, 2021
3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase
NETHERLANDS TRANSLATIONAL RES CENTER B V0 citations44
US10689343B2Jun 23, 2020
Inhibitors of tryptophan 2,3-dioxygenase
NETHERLANDS TRANSLATIONAL RES CENTER B V0 citations35
MERCK SHARP & DOHME
5 patentsUS10239883B2Mar 26, 2019
4-imidazopyridazin-1-yl-benzamides as BTK inhibitors
MERCK SHARP & DOHME6 citations82
US9758524B2Sep 12, 2017
4-imidazopyridazin-1-yl-benzamides as Btk inhibitors
MERCK SHARP & DOHME9 citations82
US9790226B2Oct 17, 2017
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BtK inhibitors
MERCK SHARP & DOHME8 citations80
US9718828B2Aug 1, 2017
BTK Inhibitors
MERCK SHARP & DOHME7 citations71
US10934296B2Mar 2, 2021
4-imidazopyridazin-1-yl-benzamides as Btk inhibitors
MERCK SHARP & DOHME0 citations60